Works matching IS 13518216 AND DT 2002 AND VI 8 AND IP 6

Results: 27

Distribution of haemophilia in the French Basque country.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 735, doi. 10.1046/j.1365-2516.2002.00659.x

By:

Bauduer, F.;
Degioanni, A.;
Ducout, L.;
Scribans, C.;
Dutour, O.

Publication type:

Article

Factor-sparing use of the COX-2 inhibitor rofecoxib in haemophilic arthropathy.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 832, doi. 10.1046/j.1365-2516.2002.00683_2.x

By:

Bragadóttir, G.;
Önundarson, P. T.

Publication type:

Article

Unresolved issues in prophylaxis.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 817, doi. 10.1046/j.1365-2516.2002.00685.x

By:

Brown, S.A.;
Aledort, L.M.;
Astermark, J.;
Berntorp, E.;
van den Berg, M.;
Blanchette, V.;
Donfield, S.;
Gringeri, A.;
Hilgartner, M.;
Kulkarni, R.;
Leissinger, C.;
Negrier, C.;
Nuss, R.;
Petterson, H.;
Petrini, P.;
Poulios, N.;
Schramm, W.

Publication type:

Article

Book Review.

Published in:

2002

By:

Gresele, P.

Publication type:

Book Review

Successful percutaneous transluminal coronary angioplasty for acute myocardial infarction in von Willebrand's disease.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 826, doi. 10.1046/j.1365-2516.2002.00681.x

By:

James, P. R.;
De Belder, A. J.;
Kenny, M. W.

Publication type:

Article

Interferon and ribavirin in HIV-negative haemophiliacs with chronic hepatitis C who were nonresponders to a previous interferon treatment.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 794, doi. 10.1046/j.1365-2516.2002.00682.x

By:

Franchini, M.;
Tagliaferri, A.;
Rossetti, G.;
Capra, F.;
Veneri, D.;
De Maria, E.;
Pattacini, C.;
Aprili, G.;
Gandini, G.

Publication type:

Article

A duplex issue: (i) time to re-appraise the diagnosis and classification of von Willebrand disorder, and (ii) clarification of the roles of von Willebrand factor collagen binding and ristocetin cofactor activity assays.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 828, doi. 10.1046/j.1365-2516.2002.00683_1.x

By:

Favaloro, E. J.

Publication type:

Article

DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 787, doi. 10.1046/j.1365-2516.2002.00678.x

By:

Kadir, R. A.;
Lee, C. A.;
Sabin, C. A.;
Pollard, D.;
Economides, D. L.

Publication type:

Article

Clinical and radiographic scores in haemophilic arthropathies: how well do these correlate to subjective pain status and daily activities?

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 802, doi. 10.1046/j.1365-2516.2002.00680.x

By:

Wallny, T.;
Lahaye, L.;
Brackmann, H. H.;
Heß, L.;
Seuser, A;
Kraft, C. N.

Publication type:

Article

Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 768, doi. 10.1046/j.1365-2516.2002.00686.x

By:

Grünewald, M.;
Siegemund, A.;
Grünewald, A.;
Konegen, A.;
Koksch, M.;
Griesshammer, M.

Publication type:

Article

First-time development of FVIII inhibitor in haemophilia patients during the postoperative period.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 776, doi. 10.1046/j.1365-2516.2002.00687.x

By:

Ghosh, K.;
Jijina, F.;
Shetty, S.;
Madkaikar, M.;
Mohanty, D.

Publication type:

Article

Clinical efficacy of highly purified, doubly virus-inactivated factor VIII/von Willebrand factor concentrate (Fanhdi<sup>®</sup> ) in the treatment of von Willebrand disease: a retrospective clinical study.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 761, doi. 10.1046/j.1365-2516.2002.00688.x

By:

Federici, A. B.;
Baudo, F.;
Caracciolo, C.;
Mancuso, G.;
Mazzucconi, M. G.;
Musso, R.;
Schinco, P. C.;
Targhetta, R.;
Mannucci, P. Mannuccio

Publication type:

Article

Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 781, doi. 10.1046/j.1365-2516.2002.00689.x

By:

Antovic, J. P.;
Antovic, A.;
He, S;
Tengborn, L.;
Blombäck, M.

Publication type:

Article

Sequential treatment with bolus and continuous infusion of recombinant factor VIIa for hip arthroplasty in a patient with haemophilia A and inhibitor.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 822, doi. 10.1046/j.1365-2516.2002.00690.x

By:

Perez, R.;
Martinez, M. L.;
Piñero, A.;
Sosa, R.

Publication type:

Article

Orthopaedic surgery in severe bleeding disorders: a low-volume, high-cost procedure.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 809, doi. 10.1046/j.1365-2516.2002.00691.x

By:

Mishra, V.;
Tjønnfjord, G. E.;
Paus, A. C.;
Vaaler, S.

Publication type:

Article

Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 753, doi. 10.1046/j.1365-2516.2002.00694.x

By:

Fischer, K.;
Astermark, J.;
Van Der Bom, J. G.;
Ljung, R.;
Berntorp, E.;
Grobbee, D. E.;
Van Den Berg, H. M.

Publication type:

Article

Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 745, doi. 10.1046/j.1365-2516.2002.00695.x

By:

Fischer, K.;
Van der Bom, J. G.;
Molho, P.;
Negrier, C.;
Mauser-Bunschoten, E. P.;
Roosendaal, G.;
De Kleijn, P.;
Grobbee, D. E.;
Van Den Berg, H. M.

Publication type:

Article

Chemical synoviorthesis with rifampicine and hyaluronic acid in haemophilic children.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 815, doi. 10.1046/j.1365-2516.2002.00696.x

By:

Athanassiou-Metaxa, M.;
Koussi, A.;
Economou, M.;
Tsagias, I.;
Badouraki, M.;
Trachana, M.;
Christodoulou, A.

Publication type:

Article

Announcement The Novo Nordisk Haemostasis Award 2003.

Published in:: Haemophilia, 2002, v. 8, n. 6, p. 835, doi. 10.1046/j.1365-2516.2002.00697_1.x
Publication type:: Article

Erratum.

Published in:: 2002
Publication type:: Erratum

Viral pharmacovigilance study of haemophiliacs receiving porcine factor VIII.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 798, doi. 10.1046/j.1365-2516.2002.00698.x

By:

Giangrande, P. L. F.;
Kessler, C. M.;
Jenkins, C. E.;
Weatherill, P. J.;
Webb, P. D.

Publication type:

Article

Inherited coagulation disorders in southern Iran.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 740, doi. 10.1046/j.1365-2516.2002.00699.x

By:

Karimi, M.;
Yarmohammadi, Hirad;
Ardeshiri, R.;
Yarmohammadi, Hooman

Publication type:

Article

Novel prothombin mutations in Puerto Rican children.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 836, doi. 10.1046/j.1365-2516.2002.d01-2_1.x

By:

Ortiz, IR;
Lefkowitz, JB;
Weller, A;
Santiago-Borrero, PJ

Publication type:

Article

Perioperative substitution therapy with plasma-derived factor VIII concentrate in patients with von Willebrand disease.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 836, doi. 10.1046/j.1365-2516.2002.d01-2_2.x

By:

Wolf, H-H;
Dorligschaw, O;
Eberspächer, B

Publication type:

Article

A high-purity double virus inactivated FVIII/vWF concentrate (Immunate) in the successful treatment of patients with von Willebrand disease.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 836, doi. 10.1046/j.1365-2516.2002.d01-2_3.x

By:

Auerswald, G;
Eberspächer, B;
Eifrid, B;
Engl, W;
Günther, C;
Koksch, M;
Kreuz, W;
Nitz, A;
Pindur, G;
Scharrer, I;
Scheel, H;
Schrieber, JD;
Siekmann, J;
Turecek, PL;
Wolf, H-H

Publication type:

Article

Inhibitor development and FVIII gene mutation analysis in a pediatric cohort treated with sucrose formulated, full-length recombinant Factor VIII.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 836, doi. 10.1046/j.1365-2516.2002.d01-2_4.x

By:

Kreuz, W.;
Leissinger, C;
Oldenburg, J;
Lusher, J;
Kelleher, J;
Gorina, E;
Kellermann, E;
Larson, P

Publication type:

Article

Table of Contents.

Published in:: 2002
Publication type:: Table of Contents